0 0 Aggrenox Sitemobilization All 1280 05

AGGRENOX is an FDA-approved prescription medication to lower the risk of stroke in people who have had either a TIA (transient ischemic attack or “mini-stroke”) or stroke due to a blood clot.

AGGRENOX combines two medications: aspirin and extended-release dipyridamole. This combination is better than either medication alone at reducing the risk of another stroke. These two medications are known as antiplatelets and they work together to make platelets in the blood less sticky, so they are less likely to clump together and form blood clots.

During a 24-month clinical study with patients who have had a TIA or a stroke due to a blood clot, patients taking AGGRENOX twice daily were 22% less likely to have a stroke than patients taking low-dose aspirin (25 mg twice daily) alone.

Over 90% of patients on AGGRENOX remained stroke-free (1493 out of a total of 1650)
AGGRENOX was twice as effective as low-dose aspirin (25 mg twice daily) at reducing the risk of a subsequent stroke when tested against a placebo.

Ask your doctor if AGGRENOX is right for you. If your doctor prescribes AGGRENOX, find out how you may be able to save on your prescription with the $10 AGGRENOX Co-pay Card offer.

Important Safety Information

Aggrenox® (aspirin/extended-release dipyridamole) 25 mg/200 mg capsules should be avoided in patients allergic to any ingredient in AGGRENOX, allergic to non-steroidal anti-inflammatory drugs (NSAIDS), or who have the combination of asthma, runny nose and nasal polyps. AGGRENOX should not be given to a child or teenager due to the risk of Reye’s syndrome.

AGGRENOX may cause an increased bleeding risk, including into the brain, stomach or intestines and any bleeding may take longer to stop. AGGRENOX should be avoided in patients with a history of stomach ulcers or those who drink three or more alcoholic drinks a day due to the risk of bleeding. Patients should inform their doctor of all medications they are currently taking including NSAIDS or blood thinners.

AGGRENOX should be avoided during pregnancy, especially in the third trimester, or in patients with severe liver or kidney problems. The most common side effects of AGGRENOX are headache, upset stomach and diarrhea.

AGGRENOX is a prescription medication used to lower the risk of stroke in people who have had a “mini-stroke” (transient ischemia attack or TIA) or stroke due to a blood clot.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information including Patient Information.

Our patient assistance program may be able to help. Call 1-800-556-8317 to find out more.

Privacy Policy  |  Terms of Use  |  Contact Us  |  Full Site

Content intended for U.S. residents only.
Copyright © 2012 - 2015 Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved.

Use of this Site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Policy.